AVDL
Avadel Pharmaceuticals
AVDL
AVDL
76 hedge funds and large institutions have $143M invested in Avadel Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 82 → 76 (-6)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
38% less call options, than puts
Call options by funds: $5.54M | Put options by funds: $8.97M
Holders
76
Holding in Top 10
2
Calls
$5.54M
Puts
$8.97M
Top Buyers
| 1 | +$2.64M | |
| 2 | +$1.7M | |
| 3 | +$1.11M | |
| 4 |
DMKJ
David M. Knott Jr
|
+$837K |
| 5 |
MWM
Modera Wealth Management
Westwood,
New Jersey
|
+$616K |
Top Sellers
| 1 | -$7.45M | |
| 2 | -$4.67M | |
| 3 | -$3.53M | |
| 4 |
Two Sigma Investments
New York
|
-$1.22M |
| 5 |
Millennium Management
New York
|
-$519K |